Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture

被引:66
作者
Lowe, GDO
机构
[1] Royal Infirm, Div Cardiovasc & Med Sci, Glasgow G31 2ER, Lanark, Scotland
[2] Glasgow Royal Infirm, Haemophilia & Thrombosis Ctr, Glasgow G4 0SF, Lanark, Scotland
关键词
thrombosis; thrombophilias; coagulation; fibrinolysis; D-dimer;
D O I
10.1111/j.1365-2141.2006.06021.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk of venous or arterial thrombosis is routinely assessed by clinical variables (risk factors) supplemented by measurement of blood lipids and glucose for arterial thrombotic events. Haematological tests that might play a role in risk prediction include haemostatic variables, haematocrit and inflammatory markers (erythrocyte sedimentation rate, plasma viscosity, white cell count). Recent epidemiological studies of these phenotypes and related genotypes are reviewed. For the risk prediction of first venous thrombosis, screening for thrombophilias in 'high-risk' situations does not appear clinically effective or cost-effective; with the possible exception of women considering oral hormone replacement therapy. General screening after a first venous event to predict recurrence (or risk in asymptomatic relatives) does not appear effective; with the possible exception of D-dimer, which requires further study. For risk prediction of first arterial thrombosis, screening adds little to prediction by current clinical risk scores. Screening of persons after a first arterial event, or with atrial fibrillation (e.g. with D-dimer for stroke prediction), requires further study. In conclusion, haematological tests have very limited roles in the prediction of cardiovascular risk, and should only be used according to evidence-based guidelines. The need for management studies is highlighted.
引用
收藏
页码:232 / 250
页数:19
相关论文
共 218 条
[1]   D-Dimer as a risk factor for deep vein thrombosis: The Leiden Thrombophilia Study [J].
Andreescu, ACM ;
Cushman, M ;
Rosendaal, FR .
THROMBOSIS AND HAEMOSTASIS, 2002, 87 (01) :47-51
[2]   Activation markers of coagulation and fibrinolysis in twins:: heritability of the prethrombotic state [J].
Ariëns, RAS ;
de Lange, M ;
Snieder, H ;
Boothby, M ;
Spector, TD ;
Grant, PJ .
LANCET, 2002, 359 (9307) :667-671
[3]   Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans [J].
Austin, H ;
Hooper, WC ;
Lally, C ;
Dilley, A ;
Ellingsen, D ;
Wideman, C ;
Wenger, NK ;
Rawlins, P ;
Silva, V ;
Evatt, B .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (10) :997-1001
[4]   Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study [J].
Baglin, T ;
Luddington, R ;
Brown, K ;
Baglin, C .
LANCET, 2003, 362 (9383) :523-526
[5]   Rebuttal: Is a nihilistic approach to thrombophilia screening justified? [J].
Baglin, T ;
Greaves, M .
THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) :700-701
[6]  
BALENDRA PR, 1990, THESIS QUEENS U BELF
[7]   Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis [J].
Bank, I ;
Libourel, EJ ;
Middeldorp, S ;
Hamulyák, K ;
van Pampus, ECM ;
Koopman, MMW ;
Prins, MH ;
van der Meer, J ;
Büller, HR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :79-84
[8]   Hemostatic function and progressing ischemic stroke - D-dimer predicts early clinical progression [J].
Barber, M ;
Langhorne, P ;
Rumley, A ;
Lowe, GDO ;
Stott, DJ .
STROKE, 2004, 35 (06) :1421-1425
[9]  
Bauer KA, 2000, THROMB HAEMOSTASIS, V84, P396
[10]   The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population [J].
Beauchamp, NJ ;
Dykes, AC ;
Parikh, N ;
Tait, RC ;
Daly, ME .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (05) :647-654